Laboratory persistence and fate of fluoxetine in aquatic environments

Environmental Toxicology and Chemistry

Volumn 25, Issue 10, 2006, Pages 2561-2568

  Kwon, Jeong Wook ^a   Armbrust, Kevin L ^a  

^a MISSISSIPPI STATE UNIVERSITY   (United States)

Author keywords

Adsorption; Fluoxetine; Photodegradation; Water sediment systems

Indexed keywords

ADSORPTION; COMPUTER SIMULATION; DRUG PRODUCTS; ENVIRONMENTAL IMPACT; FLUORESCENT LAMPS; PHOTODEGRADATION; PROTEINS; SEDIMENTS; SEWAGE SLUDGE; SOLUTIONS;

AQUATIC ENVIRONMENTS; FLUOXETINE; SYNTHETIC HUMIC WATER; WATER/SEDIMENT SYSTEMS;

MARINE BIOLOGY;

FLUOXETINE; NORFLUOXETINE; SEROTONIN UPTAKE INHIBITOR; SURFACE WATER;

ADSORPTION; AQUATIC ECOSYSTEM; DRUG; EXPERIMENTAL STUDY; HUMID ENVIRONMENT; LABORATORY METHOD; LIGHT EFFECT; PERSISTENCE; PHOTODEGRADATION; SEDIMENT; WASTE TREATMENT; WASTEWATER;

ACTIVATED SLUDGE; ADSORPTION; AQUATIC ENVIRONMENT; ARTICLE; BIODEGRADABILITY; DEMETHYLATION; DRUG DEGRADATION; DRUG STRUCTURE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROLYSIS; MICROBIAL DEGRADATION; PHOTODEGRADATION; PHOTOLYSIS; PRIORITY JOURNAL; SIMULATION; WASTE WATER MANAGEMENT;

FLUOXETINE; GEOLOGIC SEDIMENTS; SEROTONIN UPTAKE INHIBITORS; SPECTROMETRY, FLUORESCENCE; SPECTROPHOTOMETRY, ULTRAVIOLET; WATER POLLUTANTS, CHEMICAL;

EID: 33845407455     PISSN: 07307268     EISSN: None     Source Type: Journal    
DOI: 10.1897/05-613R.1     Document Type: Article

References (33)

1. Wong DT, Bymaster FP, Engleman EA. 1995. Prozac (fluoxetine, Lilly 110140), the first selective serotonin uptake inhibitor and an antidepressant drug: Twenty years since its first publication. Life Sci 57:411-441.
2. Benfield P, Heel RC, Lewis SP. 1986. Fluoxetine - A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness. Drugs 32:481-508.
3. Altmura AC, Moro AR, Percudani M. 1994. Clinical pharmacokinetics of fluoxetine. Clin Pharmacokinet 26:201-214.
4. Lemberger L, Bergstrom RF, Wolen RL, Farid NA, Enas GG, Aronoff GR. 1985. Fluoxetine: Clinical pharmacology and physiologic disposition. J Clin Psychiatry 46:14-19.
5. Fong PP. 1998. Zebra mussel spawning is induced in low concentration of putative serotonin reuptake inhibitors. Biol Bull 194:143-149.
6. Henry TB, Kwon J-W, Armbrust KL, Black MC. 2004. Acute and chronic toxicity of five selective serotonin reuptake inhibitors in Ceriodaphnia dubia. Environ Toxicol Chem 23:2229-2233.
7. Brooks BW, Turner PK, Stanley JK, Weston JJ, Glidewell EA, Foran CM, Slattery M, La Point TW, Huggett DB. 2003. Waterborne and sediment toxicity of fluoxetine to select organisms. Chemosphere 52:135-142.
8. Buser H-R, Poiger T, Müller MD. 1998. Occurrence and fate of the pharmaceutical drug diclofenac in surface water: Rapid photodegradation in a lake. Environ Sci Technol 32:3449-3456.
9. Buser H-R, Poiger T, Müller MD. 1999. Occurrence and environmental behavior of the chiral pharmaceutical drug ibuprofen in surface water and in wastewater. Environ Sci Technol 33:2529-2535.
10. Daughton CG, Ternes TA. 1999. Pharmaceuticals and personal care products in the environment: Agents of subtle change? Environ Health Perspect 107:907-938.
11. Vanderford BJ, Pearson RA, Rexing DJ, Snyder SA. 2003. Analysis of endocrine disruptors, pharmaceuticals, and personal care products in water using liquid chromatography/tandem mass spectrometry. Anal Chem 75:6265-6274.
12. Metcalfe CD, Miao X-S, Koenig BG, Struger J. 2003. Distribution of acidic and neutral drugs in surface water near sewage treatment plants in the lower Great Lakes, Canada. Environ Toxicol Chem 22:2881-2889.
13. Metcalfe CD, Koenig BG, Bennie DT, Servos M, Ternes TA, Hirsch R. 2003. Occurrence of neutral and acidic drugs in the effluents of Canadian sewage treatment plants. Environ Toxicol Chem 22:2872-2880.
14. Boyd GR, Reemtsma H, Grimm DA, Mitra S. 2003. Pharmaceuticals and personal care products (PPCPs) in surface and treated water of Louisiana, USA. and Ontario, Canada. Sci Total Environ 311:135-149.
15. Coyne R, Hiney M, O'Conner B, Cazabon D, Smith P. 1994. Concentration and persistence of oxytetracycline in sediments under a marine salmon farm. Aquaculture 123:31-42.
16. Kerry J, Hiney M, Coyne R, NicGabhainn S, Gilroy D, Cazabon D, Smith P. 1995. Fish feed as a source of oxytetracycline-resistent bacteria in the sediment under fish farms. Aquaculture 131:101-113.
17. Kolpin DW, Furlong ET, Meyer MT, Thurman EM, Zaugg SD, Barber LB, Buxton HT. 2002. Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. streams, 1999-2000: A national reconnaissance. Environ Sci Technol 36:1202-1211.
18. Lam MW, Young CJ, Mabury SA. 2005. Aqueous photochemical reaction kinetics and transformations of fluoxetine. Environ Sci Technol 39:513-522.
19. Brooks BW, Chambliss CK, Stanley JK, Ramirez A, Banks KE, Johnson RD, Lewis RJ. 2005. Determination of select antidepressants in fish from an effluent-dominated stream. Environ Toxicol Chem 24:464-469.
20. Kwon J-W, Armbrust KL. 2004. Hydrolysis and photolysis of paroxetine, a selective serotonin reuptake inhibitor, in aqueous solutions. Environ Toxicol Chem 23:1394-1399.
21. U.S. Environmental Protection Agency. 1998. Fate, transport, and transformation test guidelines - OPPTS 835.5270, Indirect photolysis screening test. EPA/712-C-98-099. Washington, DC.
22. Malcolm RL, MacCarthy P. 1986. Limitations in the use of humic acids in water and soil research. Environ Sci Technol 20:904-911.
23. Kwon J-W, Armbrust KL. 2005. Photoisomerization of fluvoxamine in aqueous solutions. J Pharm Biomed Anal 37:643-648.
24. U.S. Environmental Protection Agency. 1998. Fate, transport, and transformation test guidelines - OPPTS 835.3110, Ready biodegradability. EPA/712-C-98-076. Washington, DC.
25. Peterson JA, Risley DS, Anderson PN, Hostettler KF. 1994. Stability of fluoxetine hydrochloride in fluoxetine solution diluted with common pharmaceutical diluents. American Journal of Hospital Pharmacy 51:1342-1345.
26. Souter RW, Dinner A. 1976. GLC determination of degradation of two related amine uptake inhibitors. J Pharm Sci 65:457-459.
27. Risley DS, Bopp RJ. 1990. Fluoxetine. In Florey K, ed, Analytical Profiles of Drug Substances, Vol 19. Academic, New York, NY, USA, pp 193-219.
28. Sakkas VA, Konstantinou IK, Albanis TA. 2001. Photodegradation study of the antifouling booster biocide dichlofluanid in aqueous media by gas chromatographic techniques. J Chromatogr A 930:135-144.
29. Lam MW, Tantuco K, Mabury SA. 2003. Photofate: A new approach in accounting for the contribution of indirect photolysis of pesticides and pharmaceuticals in surface waters. Environ Sci Technol 37:899-907.
30. Kinney CA, Furlong ET, Cahill JD, Werner SL. 2004. Occurrence and behavior of wastewater derived pharmaceuticals in soils irrigated with reclaimed water. Proceedings, 227th American Chemical Society National Meeting, Anaheim, CA, USA, March 28-April 1, p 49.
31. Furlong ET, Kinney CA, Ferrer I. 2004. Pharmaceuticals and personal-care products in solids: Analysis and field results for sediment, soil, and biosolid samples. Proceedings, 228th American Chemical Society National Meeting, Philadelphia, PA, USA, August 22-26, p 37.
32. Sutherland FCW, de Jager AD, Badenhorst D, Scanes T, Hundt HKL, Swart KJ, Hundt AF. 2001. Sensitive liquid chromatogra-phy-tandem mass spectrometry method for the determination of loratadine and its major active metabolite descarboethoxyloratadine in human plasma. J Chromatogr 914:37-43.
33. Sutherland FCW, Badenhorst D, de Jager AD, Scanes T, Hundt HKL, Swart KJ, Hundt AF. 2001. Sensitive liquid chromatography-tandem mass spectrometric method for the determination of fluoxetine and its primary active metabolite norfluoxetine in human plasma. J Chromatogr 914:45-51.